首页> 外文期刊>Pharmacological reviews >International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors.
【24h】

International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors.

机译:国际药理学联合会XXXVII。白三烯和脂氧合蛋白受体的命名法。

获取原文
获取原文并翻译 | 示例
           

摘要

The leukotrienes and lipoxins are biologically active metabolites derived from arachidonic acid. Their diverse and potent actions are associated with specific receptors. Recent molecular techniques have established the nucleotide and amino acid sequences and confirmed the evidence that suggested the existence of different G-protein-coupled receptors for these lipid mediators. The nomenclature for these receptors has now been established for the leukotrienes. BLT receptors are activated by leukotriene B(4) and related hydroxyacids and this class of receptors can be subdivided into BLT(1) and BLT(2). The cysteinyl-leukotrienes (LT) activate another group called CysLT receptors, which are referred to as CysLT(1) and CysLT(2). A provisional nomenclature for the lipoxin receptor has also been proposed. LXA(4) and LXB(4) activate the ALX receptor and LXB(4) may also activate another putative receptor. However this latter receptor has not been cloned. The aim of this review is to provide the molecular evidence as well as the properties and significance of the leukotriene and lipoxin receptors, which has lead to the present nomenclature.
机译:白三烯和脂蛋白是衍生自花生四烯酸的生物活性代谢产物。它们的多样而有效的作用与特定的受体有关。最近的分子技术已经建立了核苷酸和氨基酸序列,并证实了表明这些脂质介体存在不同的G蛋白偶联受体的证据。现在已经为白三烯建立了这些受体的命名法。 BLT受体由白三烯B(4)和相关的羟基酸激活,这类受体可细分为BLT(1)和BLT(2)。半胱氨酰白三烯(LT)激活另一个称为CysLT受体的基团,称为CysLT(1)和CysLT(2)。还提出了脂蛋白受体的临时命名法。 LXA(4)和LXB(4)激活ALX受体,LXB(4)也可能激活另一个推定的受体。然而,该后一种受体尚未被克隆。这篇综述的目的是提供白三烯和脂蛋白受体的分子证据以及性质和意义,这导致了目前的命名法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号